Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis: An assessment of clinical significance when viewed as a risk factor for cardiovascular disease
Open Access
- 30 September 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 27 (3) , 434-438
- https://doi.org/10.1016/0190-9622(92)70213-y
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hypertriglyceridemia in patients with psoriasis treated with cyclosporineJournal of the American Academy of Dermatology, 1991
- Cyclosporine for Plaque-Type PsoriasisNew England Journal of Medicine, 1991
- Management of patients and side effects during cyclosporine therapy for cutaneous disordersJournal of the American Academy of Dermatology, 1990
- Renal function and blood pressure in psoriatic patients treated with cyclosporin ABritish Journal of Dermatology, 1990
- Side-effect profile of cyclosporin A in patients treated for psoriasisBritish Journal of Dermatology, 1990
- Low-dose cyclosporin A in severe psoriasis. A double-blind studyBritish Journal of Dermatology, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Treatment of resistant severe psoriasis with systemic cyclosporineJournal of the American Academy of Dermatology, 1987
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978